Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line

MLA

Eiju Negoro, et al. “Combination of Guanine Arabinoside and Bcl-2 Inhibitor YC137 Overcomes the Cytarabine Resistance in HL-60 Leukemia Cell Line.” Cancer Science, vol. 104, Feb. 2013, pp. 502–07. EBSCOhost, https://doi.org/10.1111/cas.12103.

APA

Eiju Negoro, Rie Nishi, Haruyuki Takemura, Takanori Ueda, & Takahiro Yamauchi. (2013). Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line. Cancer Science, 104, 502–507. https://doi.org/10.1111/cas.12103

Chicago

Eiju Negoro, Rie Nishi, Haruyuki Takemura, Takanori Ueda, and Takahiro Yamauchi. 2013. “Combination of Guanine Arabinoside and Bcl-2 Inhibitor YC137 Overcomes the Cytarabine Resistance in HL-60 Leukemia Cell Line.” Cancer Science 104 (February): 502–7. doi:10.1111/cas.12103.